Veracyte, Inc.

Filed a patent for "use of genomic signatures to predict responsiveness of patients with prostate cancer to post-operative radiation therapy" on Thu, May 18, 2023

Filed a patent for "cancer biomarkers and classifiers and uses thereof" on Thu, July 13, 2023

Filed a patent for "nano46 genes and methods to predict breast cancer outcome" on Thu, August 31, 2023

Filed a patent for "genomic classifiers for prognosing and treating clinically aggressive luminal bladder cancer" on Thu, April 13, 2023

Filed a patent for "methods and genomic classifiers for identifying homologous recombination deficiency prostate cancer" on Thu, January 4, 2024

Filed a patent for "use of immune content scores diagnostically to predict responsiveness of prostate cancer patients to immunotherapy" on Fri, July 14, 2023